Health
Scientists study the sensitivity of SARS-CoV-2 variants to neutralize antibodies – News-Medical.Net
The B.1.1.7 and B.1.351 variants of SARS-CoV-2 were first detected in the UK and South Africa respectively, and have since spread to many other countries.
The B.1.1.7 and B.1.351 variants of SARS-CoV-2 were first detected in the UK and South Africa respectively, and have since spread to many other countries.
Scientists from the Institut Pasteur joined forces with Orléans Regional Hospital, Tours University Hospital, Créteil Intercommunal Hospital, Strasbourg University Hospital and Georges Pompidou European Hospital to study the sensitivity of these two variants to neutralizing antibodies present in the serum samples of people who have been vaccinated…
-
General23 hours agoSenator Jacinta Nampijinpa Price appears at Liberal Party fundraiser in Perth, a day after front bench axing
-
Noosa News16 hours agoCool but settled spring weekend weather ahead for Queensland
-
Noosa News17 hours agoWin double passes to Heart of Gold!
-
Business17 hours agoHow to retire early using dividend-paying ASX stocks